Stephen Arbib

Stephen Arbib appears in our data through filings on MedReleaf Corp. shares, published by SEDI. In total, 12 filings cover trades dated from 30 May 2017 to 13 April 2018.

The open-market record consists of 7 sales worth €1.6M, with no purchase. In 2018 alone, the filings show no purchases and 4 sales.

The newest entry dates from 18 April 2018: an open-market sale of €407k, in MedReleaf Corp. Filings reach the SEDI feed a median of 3 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEDI disclosures alone and does not predict where the share price will go.